Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-000625

Baxalta Inc · BXLT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David D. Meek
Officer — EVP and President, Oncology
Period of report
Jul 1, 2015
Accepted (ET)
Jul 6, 2015 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.01 per shareF1Jul 1, 2015J25,068$0.00A25,068D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F3$34.29Jul 1, 2015J43,334A—Sep 2, 2024Common Stock, par value $0.01 per share43,33443,334D
Stock Option (Right to Buy)F2,F4$32.04Jul 1, 2015J54,553A—Mar 3, 2025Common Stock, par value $0.01 per share54,55354,553D
Stock Option (Right to Buy)F5$31.50Jul 1, 2015A191,421A—Jul 1, 2025Common Stock, par value $0.01 per share191,421191,421D
Stock Option (Right to Buy)F6$31.50Jul 1, 2015A6,155A—Jul 1, 2025Common Stock, par value $0.01 per share6,1556,155D

Explanation of responses